71.51
0.35%
-0.25
Handel nachbörslich:
71.51
Schlusskurs vom Vortag:
$71.76
Offen:
$69.74
24-Stunden-Volumen:
334.04K
Relative Volume:
1.18
Marktkapitalisierung:
$1.32B
Einnahmen:
$1.77M
Nettoeinkommen (Verlust:
$-123.74M
KGV:
-23.60
EPS:
-3.03
Netto-Cashflow:
$-95.21M
1W Leistung:
-15.70%
1M Leistung:
-2.31%
6M Leistung:
+57.55%
1J Leistung:
+6,843%
Praxis Precision Medicines Inc Stock (PRAX) Company Profile
Firmenname
Praxis Precision Medicines Inc
Sektor
Branche
Telefon
617-300-8460
Adresse
99 HIGH STREET, 30TH FLOOR, BOSTON
Vergleichen Sie PRAX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
PRAX | 71.51 | 1.32B | 1.77M | -123.74M | -95.21M | -3.03 |
VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Praxis Precision Medicines Inc Stock (PRAX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2023-09-19 | Eingeleitet | Truist | Buy |
2022-06-06 | Herabstufung | Wedbush | Outperform → Neutral |
2021-12-16 | Eingeleitet | H.C. Wainwright | Buy |
2021-08-26 | Eingeleitet | BofA Securities | Buy |
2021-04-26 | Eingeleitet | William Blair | Outperform |
2020-11-11 | Eingeleitet | Wedbush | Outperform |
2020-11-10 | Eingeleitet | Cowen | Outperform |
2020-11-10 | Eingeleitet | Evercore ISI | Outperform |
2020-11-10 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Praxis Precision Medicines Inc Aktie (PRAX) Neueste Nachrichten
Praxis Precision Medicines (NASDAQ:PRAX) Shares Gap Down Following Insider Selling - MarketBeat
CIBC Asset Management Inc Acquires 56,272 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
Alex Nemiroff Sells 8,239 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Stock - MarketBeat
Insider Selling: Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Insider Sells 5,188 Shares of Stock - MarketBeat
(PRAX) Proactive Strategies - Stock Traders Daily
Praxis Precision Medicines principal accounting officer sells $424,318 in stock By Investing.com - Investing.com Australia
Praxis Precision Medicines' general counsel sells shares worth $660,827 - Investing.com
Praxis Precision Medicines principal accounting officer sells $424,318 in stock - Investing.com
Praxis Precision Medicines (NASDAQ:PRAX) Trading Down 7.9%Should You Sell? - MarketBeat
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Cormorant Asset Management's Strategic Acquisition in Praxis Pre - GuruFocus.com
Verition Fund Management LLC Adjusts Stake in Praxis Precision M - GuruFocus.com
Capital Research Global Investors Acquires New Stake in Praxis P - GuruFocus.com
FY2024 Earnings Estimate for PRAX Issued By HC Wainwright - MarketBeat
Equities Analysts Offer Predictions for PRAX FY2024 Earnings - MarketBeat
Praxis Precision Medicines Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
HC Wainwright Reiterates "Buy" Rating for Praxis Precision Medicines (NASDAQ:PRAX) - MarketBeat
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Q3 2024 Earnings Call Transcript - Insider Monkey
Praxis Precision Medicines Inc (PRAX) Is Worth A Look Now, Despite -5.10% Loss From High - Stocks Register
Praxis Precision Medicines Inc (PRAX) Q3 2024 Earnings Call Highlights: Strong Cash Position ... - Yahoo Finance
Praxis Precision Medicines Inc (PRAX) Q3 2024 Earnings Call Highlights: Strong Cash Position ... By GuruFocus - Investing.com Canada
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2024 Financial Results - citybiz
Praxis Precision Medicines Reports Q3 2024 Results and Progress - TipRanks
Praxis Precision Medicines, Inc. (PRAX) Reports Q3 Loss, Misses Revenue Estimates - MSN
Praxis Precision Medicines to Participate in Three Upcoming November Investor Conferences - GlobeNewswire
Praxis Precision Medicines to Present at Three Major Healthcare Conferences in November | PRAX Stock News - StockTitan
Praxis Precision Advances CNS Disorder Therapies - TipRanks
Q3 2024 Praxis Precision Medicines Inc Earnings Call Transcript - GuruFocus.com
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2024 Financial - The Bakersfield Californian
How the (PRAX) price action is used to our Advantage - Stock Traders Daily
Vanguard Group Inc's Strategic Acquisition in Praxis Precision M - GuruFocus.com
Assenagon Asset Management S.A. Decreases Stock Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
Praxis Precision Medicines (PRAX) to Release Quarterly Earnings on Wednesday - MarketBeat
Praxis Precision Medicines to Announce Third Quarter 2024 - GlobeNewswire
Praxis Precision Medicines to Announce Third Quarter 2024 Financial Results and Host Conference Call on Wednesday, November 6, 2024 - The Manila Times
(PRAX) Trading Advice - Stock Traders Daily
Moody Aldrich Partners LLC Purchases 7,224 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
We're Not Very Worried About Praxis Precision Medicines' (NASDAQ:PRAX) Cash Burn Rate - Yahoo Finance
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Praxis Precision To Report Aria Study Data In June - RTTNews
Will Praxis Precision Hit The Targets? - RTTNews
Praxis Precision Medicines revises executive severance terms - Investing.com
Where are the Opportunities in (PRAX) - Stock Traders Daily
Praxis Precision Medicines revises executive severance terms By Investing.com - Investing.com Australia
Praxis Precision To Reveal Key Trial Data On Essential Tremors - RTTNews
Dimensional Fund Advisors LP Sells 8,152 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
Praxis Precision shares get boost on DEE space acquisition interest - Investing.com India
Praxis Precision Medicines (NASDAQ:PRAX) Reaches New 52-Week HighHere's Why - MarketBeat
Praxis Precision shares get boost on DEE space acquisition interest By Investing.com - Investing.com South Africa
Praxis stock soars to 52-week high, hits $68 amid robust gains - Investing.com
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Sold by Millennium Management LLC - MarketBeat
Finanzdaten der Praxis Precision Medicines Inc-Aktie (PRAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):